Also trades as: PPCBD (OTC) · $vol 0M
PPCB NASDAQ
Propanc Biopharma, Inc.
1W: -19.5%
1M: -50.7%
3M: -73.0%
YTD: -11.2%
1Y: -70.2%
3Y: -100.0%
5Y: -99.0%
$0.51
+0.01 (+1.30%)
Weekly Expected Move ±14.3%
$0
$0
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
75 relationships75
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-03-19
Earliest Filing
2025-08-19
Latest Filing
partner: 35
investor: 35
acquirer: 3
customer: 2
Counterparties (Filed by PPCB)
75 relationshipsCompanies named in PPCB's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Propanc Biopharma, Inc. | PPCB | partner | Company issuing common stock in the offering | 2025-08-19 | View |
| D. Boral Capital LLC | — | partner | Representative of the underwriters | 2025-08-19 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing the note | 2025-07-30 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing the note | 2025-07-30 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing bridge notes to Buyer | 2025-06-27 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing bridge notes from Company | 2025-06-27 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing the convertible note | 2025-06-18 | View |
| GEEBIS CONSULTING, LLC | — | investor | Buyer purchasing the convertible note | 2025-06-18 | View |
| Propanc Biopharma Inc. | PPCB | acquirer | Company entering maturity extension agreement | 2025-05-08 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing 8% convertible notes | 2025-04-21 | View |
| GS CAPITAL PARTNERS, LLC | — | investor | Buyer purchasing $55,000 aggregate principal amount of convertible notes | 2025-04-21 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing the convertible note | 2025-03-18 | View |
| GS CAPITAL PARTNERS, LLC | — | investor | Buyer purchasing the convertible note | 2025-03-18 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing bridge notes | 2025-02-12 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing bridge notes | 2025-02-12 | View |
| GEEBIS CONSULTING, LLC | — | investor | Buyer purchasing convertible notes | 2024-12-20 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing 8% convertible notes | 2024-12-20 | View |
| GS CAPITAL PARTNERS, LLC | — | investor | Buyer purchasing convertible notes | 2024-09-27 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing 8% convertible notes | 2024-09-27 | View |
| 104 LLC | — | investor | Buyer purchasing the promissory note | 2024-07-02 | View |
| Propanc Biopharma, Inc. | PPCB | partner | Company issuing the promissory note | 2024-07-02 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing bridge note | 2024-06-21 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing bridge note | 2024-06-21 | View |
| Propanc Biopharma Inc. | PPCB | customer | Received a loan of AUD 20,000 from Susan Loizou. | 2024-06-13 | View |
| Propane Biopharma Inc. | — | customer | Received a loan of AUD 20,000 from Susan Loizou. | 2024-06-12 | View |
| Ionic Ventures, LLC | — | investor | Holder of the 10% OID Promissory Note | 2024-05-16 | View |
| Propanc Biopharma Inc. | PPCB | acquirer | Company entering maturity extension agreement | 2024-05-16 | View |
| GS CAPITAL PARTNERS, LLC | — | investor | Buyer purchasing convertible notes | 2024-04-22 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing 8% convertible notes | 2024-04-22 | View |
| 104 LLC | — | investor | Buyer purchasing the promissory note | 2024-03-11 | View |
| Propanc Biopharma, Inc. | PPCB | partner | Company issuing the promissory note | 2024-03-11 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing the convertible note | 2023-12-15 | View |
| ONE44 CAPITAL LLC | — | investor | Buyer purchasing the convertible note | 2023-12-15 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2023-12-07 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing convertible notes | 2023-12-07 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing the convertible note | 2023-10-17 | View |
| GS CAPITAL PARTNERS, LLC | — | investor | Buyer purchasing the convertible note | 2023-10-17 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing 8% convertible notes | 2023-08-29 | View |
| GS CAPITAL PARTNERS, LLC | — | investor | Buyer purchasing convertible notes | 2023-08-29 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing convertible note | 2023-08-21 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible note | 2023-08-21 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing convertible notes | 2023-08-08 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2023-08-08 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2023-07-12 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing convertible notes | 2023-07-12 | View |
| Propanc Biopharma, Inc. | PPCB | acquirer | Company issuing securities in this agreement | 2023-05-15 | View |
| Coventry Enterprises, LLC | — | investor | Investor purchasing the Promissory Note | 2023-05-15 | View |
| Red Road Holdings Corporation | — | investor | Buyer purchasing convertible notes | 2022-10-12 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2022-10-12 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing 8% convertible notes | 2022-09-27 | View |
| GS CAPITAL PARNTERS, LLC | — | investor | Buyer purchasing convertible notes | 2022-09-27 | View |
| GS CAPITAL PARNTERS, LLC | — | investor | Buyer purchasing the convertible note | 2022-08-18 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing the convertible note | 2022-08-18 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2022-07-07 | View |
| 1800 DIAGONAL LENDING LLC | — | investor | Buyer purchasing convertible notes | 2022-07-07 | View |
| SIXTH STREET LENDING LLC | — | investor | Buyer purchasing convertible notes | 2022-04-18 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2022-04-18 | View |
| ONE44 CAPITAL LLC | — | investor | Buyer purchasing convertible notes | 2022-04-01 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2022-04-01 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2022-03-10 | View |
| SIXTH STREET LENDING LLC | — | investor | Buyer purchasing convertible notes | 2022-03-10 | View |
| SIXTH STREET LENDING LLC | — | investor | Buyer purchasing convertible notes | 2022-01-10 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2022-01-10 | View |
| ONE44 CAPITAL LLC | — | investor | Buyer purchasing the convertible note | 2021-12-13 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing the convertible note | 2021-12-13 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2021-12-01 | View |
| SIXTH STREET LENDING LLC | — | investor | Buyer purchasing convertible notes | 2021-12-01 | View |
| SIXTH STREET LENDING LLC | — | investor | Buyer purchasing convertible notes | 2021-10-27 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2021-10-27 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible note | 2021-09-28 | View |
| GENEVA ROTH REMARK HOLDINGS, INC. | — | investor | Buyer purchasing convertible note | 2021-09-28 | View |
| GENEVA ROTH REMARK HOLDINGS, INC. | — | investor | Buyer purchasing convertible notes | 2021-08-25 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2021-08-25 | View |
| PROPANC BIOPHARMA, INC. | PPCB | partner | Company issuing convertible notes | 2021-03-19 | View |
| GENEVA ROTH REMARK HOLDINGS, INC. | — | investor | Buyer purchasing convertible notes | 2021-03-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-14 | Officer/Director Change; Exhibits | View | |
| 2026-02-26 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-07 | Notice of Delisting or Transfer | View | |
| 2025-11-10 | Unregistered Sales of Equity Securities; Amendments to Articles of Incorporation or Bylaws; Financia | View | |
| 2025-10-14 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-19 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2025-08-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-07-30 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-07-22 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-06-27 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-06-18 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-06-02 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-05-08 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-04-21 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-03-18 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-02-12 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-12-20 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-12-06 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2024-09-27 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-08-30 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR